Camille L Bedrosian
Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $689K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 14SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 7,947280,145 held (−3%) | $32.21 | $256K | -12.6% |
| Sep 14SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 2,081278,064 held (−1%) | $33.09 | $69K | -15.0% |
| Mar 4SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 6,461169,295 held (−4%) | $14.58 | $94K | +93.0% |
| Dec 3SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 6,580175,756 held (−4%) | $14.35 | $94K | +96.1% |
| Oct 2SEC | AMLXAmylyx Pharmaceuticals, Inc. | Sell | 12,039182,336 held (−6%) | $14.58 | $176K | +93.0% |